期刊
JOURNAL OF FUNGI
卷 2, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/jof2030021
关键词
Aspergillus fumigatus; aspergillosis; azole drug resistance; cyp51A; mutations
资金
- Fondo de Investigaciones Sanitarias [FI14CIII/00025]
Since the first description of an azole-resistant A. fumigatus strain in 1997, there has been an increasing number of papers describing the emergence of azole resistance. Firstly reported in the USA and soon after in Europe, it has now been described worldwide, challenging the management of human aspergillosis. The main mechanism of resistance is the modification of the azole target enzyme: 14-alpha sterol demethylase, encoded by the cyp51A gene; although recently, other resistance mechanisms have also been implicated. In addition, a shift in the epidemiology has been noted with other Aspergillus species (mostly azole resistant) increasingly being reported as causative agents of human disease. This paper reviews the current situation of Aspergillus azole resistance and its implications in the clinical setting.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据